Immune disorders in sepsis and their treatment as a significant problem of modern intensive care
Despite the great advances in the treatment of sepsis over the past 20 years, sepsis remains the main cause of death in intensive care units. In the context of new possibilities of treating sepsis, a comprehensive response of the immune system to the infection, immunosuppression, in particular, has...
Main Authors: | Lidia Łysenko, Patrycja Leśnik, Kamil Nelke, Hanna Gerber |
---|---|
Format: | Article |
Language: | English |
Published: |
Index Copernicus International S.A.
2017-08-01
|
Series: | Postępy Higieny i Medycyny Doświadczalnej |
Subjects: | |
Online Access: | http://phmd.pl/gicid/01.3001.0010.3849 |
Similar Items
-
Thymosin alpha1 based immunomodulatory therapy for sepsis: a systematic review and meta-analysis
by: Congcong Li, et al.
Published: (2015-04-01) -
The effects of ursodeoxycholic acid on sepsis-induced cholestasis management in an animal model
by: Randa H. Ainosah, MSc, et al.
Published: (2020-08-01) -
Significance of Serum Procalcitonin Level in the Early Diagnosis of Neonatal Sepsis
by: Raid M. R. Umran, et al.
Published: (2020-08-01) -
The Effect of Statins Use on the Risk and Outcome of Acute Bacterial Infections in Adult Patients
by: Mohammad Nassaji, et al.
Published: (2015-11-01) -
The severe COVID-19: A sepsis induced by viral infection? And its immunomodulatory therapy
by: Hong-Yuan Lin
Published: (2020-08-01)